← Back to Search

Dietary Supplement

Cranberry extract capsules for Urinary Incontinence

N/A
Waitlist Available
Led By Lieschen Quiroz, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial will study whether or not cranberry extracts can help prevent urinary tract infections in women who have had surgery for urinary incontinence.

Eligible Conditions
  • Urinary Incontinence
  • Urinary Tract Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Urine culture based on type of symptoms
Secondary outcome measures
Duration of symptoms

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cranberry Extract CapsulesExperimental Treatment1 Intervention
36mg of proanthocyanidins in cranberry capsules
Group II: Placebo CapsulesPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cranberry extract capsules
2021
N/A
~180

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
95,515 Total Patients Enrolled
Lieschen Quiroz, MDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
232 Total Patients Enrolled
~23 spots leftby Jun 2025